Carlos Daniel Coronado-Alvarado

Dr. Carlos Daniel Coronado-Alvarado

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2025 in Clinical & Experimental Metastasis
Verified
Journal Article
Open access
PDF file
CCCarlos Daniel Coronado-Alvarado
Carlos Daniel Coronado-Alvarado
HAHumberto Astiazaran-Garcia
Humberto Astiazaran-Garcia
Bone disorders frequently manifest as long-term outcomes of breast cancer. Consequently, the relationship between breast cancer and bone metabolism is often studied at advanced stages of the disease. Emerging evidence suggests that bidirectional communication between mammary and bone tissues begins much earlier. In this context, extracellular vesicles (EVs) have been recognized as key mediators of intercellular communication, with emerging evidence supporting their role in breast cancer progression and the regulation of bone metabolism. This review examines bone imbalances occurring throughout the course of breast cancer, the pathophysiological mechanisms behind them, and the role of EVs in their development. From this integrated perspective, we propose the concept of Tumor-Bone Axis, a continuous and dynamic crosstalk between breast cancer and bone cells that supports tumor progression and bone complications. This axis regulates distinct metabolic states governing the activity of breast cancer cells and the balance in bone remodeling, enabling cellular reprogramming events during malignant transformation, immunoediting, tumor growth, and metastasis formation. Additionally, the impact of antineoplastic treatments on this axis may underlie chemoresistance, relapse, or therapy-induced metastasis. While multiple mediators are involved—including cell-to-cell contact, cell migration, osteoimmune interactions, hormones, soluble factors, and nutrients—EVs appear to be critical, especially through their role in exchanging epigenetic regulators of central signaling pathways in these cellular reprogramming events. Understanding the temporal and functional dynamics of the Tumor-Bone Axis and the extracellular vesicular traffic within it could reveal novel diagnostic biomarkers and therapeutic strategies for both breast cancer and its bone-related manifestations.

29 October 2025 in BIOtecnia
Verified
Journal Article
Open access
PDF file
LVLiliana Ruiz Velazquez
Liliana Ruiz Velazquez
GFGloria Guadalupe Morales Figueroa
Gloria Guadalupe Morales Figueroa
AVAdriana Verónica Bolaños Villar
Adriana Verónica Bolaños Villar
A´Alma Delia Contreras ´pAniagua
Alma Delia Contreras ´pAniagua
CCCarlos Daniel Coronado-Alvarado
Carlos Daniel Coronado-Alvarado
HAHumberto Astiazaran-Garcia
Humberto Astiazaran-Garcia
El cáncer de mama y su tratamiento antineoplásico aceleran la pérdida de masa ósea, aumentando el riesgo de osteoporosis y fracturas. La dieta, como factor modificable, puede desempeñar un papel clave en este proceso. Este estudio tuvo como objetivo evaluar la asociación entre patrones dietéticos y el estado óseo en mujeres mexicanas con diagnóstico reciente de cáncer de mama. Se llevó a cabo un estudio transversal piloto con dos grupos pareados por edad: uno con diagnóstico reciente de cáncer de mama y otro sin enfermedad. El estado óseo y la composición corporal se evaluaron mediante absorciometría dual de rayos X, y la ingesta dietética mediante un cuestionario de frecuencia de consumo de alimentos. A través de análisis de componentes principales se identificaron tres patrones dietéticos. El patrón denominado “Desayuno”, compuesto por productos lácteos, huevo, café, té y cereales refinados, mostró una asociación positiva con la densidad mineral ósea lumbar (β = 0.043; p = 0.020). El patrón “Occidentalizado” presentó una tendencia negativa cercana al umbral de significancia (p = 0.053), mientras que el patrón “Tradicional-mexicano” no mostró asociación. Estos hallazgos resaltan la importancia de promover patrones dietéticos que favorezcan la salud ósea en mujeres con cáncer de mama.

27 July 2023 in Current Developments in Nutrition
Verified
Journal Article
Open access
HAHumberto Astiazaran-Garcia
Humberto Astiazaran-Garcia
HMHerminia Mendivil-Alvarado
Herminia Mendivil-Alvarado
Ana Teresa Limon-MiroAna Teresa Limon-Miro
Ana Teresa Limon-Miro
Elizabeth Carvajal-MillanElizabeth Carvajal-Millan
Elizabeth Carvajal-Millan
JLJaime Lizardi-Mendoza
Jaime Lizardi-Mendoza
DTDaniel Talamás-Lara
Daniel Talamás-Lara

19 April 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
CCCarlos Daniel Coronado-Alvarado
Carlos Daniel Coronado-Alvarado
ALAna Teresa Limon-Miro
Ana Teresa Limon-Miro
HMHerminia Mendivil-Alvarado
Herminia Mendivil-Alvarado
JLJaime Lizardi-Mendoza
Jaime Lizardi-Mendoza
Elizabeth Carvajal-MillanElizabeth Carvajal-Millan
Elizabeth Carvajal-Millan
HAHumberto Astiazaran-Garcia
Humberto Astiazaran-Garcia
Extracellular vesicles (EVs) are implicated in several biological conditions, including bone metabolism disturbances in breast cancer patients (BCPs). These disorders hinder the adjustment of nutrition interventions due to changes in bone mineral density (BMD). The biophysical properties of EVs (e.g., size or electrostatic repulsion) affect their cellular uptake, however, their clinical relevance is unclear. In this study, we aimed to investigate the association between the biophysical properties of the plasma-derived EVs and BMDs in BCPs who received an individualized nutrition intervention during the first six months of antineoplastic treatment. As part of the nutritional assessment before and after the intervention, body composition including bone densitometry and plasma samples were obtained. In 16 BCPs, EVs were isolated using ExoQuick® and their biophysical properties were analyzed using light-scattering techniques. We found that the average hydrodynamic diameter of large EVs was associated with femoral neck bone mineral content, lumbar spine BMD, and neoplasms’ molecular subtypes. These results provide evidence that EVs play a role in BCPs’ bone disorders and suggest that the biophysical properties of EVs may serve as potential nutritional biomarkers. Further studies are needed to evaluate EVs’ biophysical properties as potential nutritional biomarkers in a clinical context.